References
- Vandeputte MM, Van Uytfanghe K, Layle NK, et al. Synthesis, chemical characterization, and μ-opioid receptor activity assessment of the emerging group of “nitazene” 2-benzylbenzimidazole synthetic opioids. ACS Chem Neurosci. 2021;12(7):1241–1251.
- Haden M, Cashman J, Ketchin A, et al. Detection of flubromazolam in patients with suspected non-medical drug use attending emergency departments in the United Kingdom. Clin Toxicol. 2021:1–5. DOI:10.1080/15563650.2021.1931692
- Blanckaert P, Balcaen M, Vanhee C, et al. Analytical characterization of “etonitazepyne,” a new pyrrolidinyl-containing 2-benzylbenzimidazole opioid sold online. Drug Test Anal. 2021;13(9):1627–1634.
- Krotulski AJ, Papsun DM, Walton SE, et al. New high potency synthetic opioid n-pyrrolidino etonitazene (etonitazepyne) linked to overdoses across United States [cited 2021 Aug 9]. Available from: https://www.npsdiscovery.org/wp-content/uploads/2021/06/Public-Alert_N-Pyrrolidino-Etonitazene_NPS-Discovery_061721.pdf